Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

SONN Sonnet BioTherapeutics Holdings Inc

1,54

0,00 (0,00%)

18 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Sonnet BioTherapeutics Charts.

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Sonnet BioTherapeutics Charts.

News Sonnet BioTherapeutics Holdings Inc

Form POS AM - Post-Effective amendments for registration statement
Montag 13 Januar 2025 (7 Tage vor) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Montag 23 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment
Montag 23 Dezember 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 17 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 17 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
Dienstag 17 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 10 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Dienstag 10 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Montag 9 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 9 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial
Montag 9 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 6 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Sonnet BioTherapeutics Holdings Inc News-Artikel

BNP Paribas (QX)

Deutsche Telekom (QX)

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen